$9.61
$0.00 (0.00%)
End-of-day quote: 06/01/2024
NasdaqCM:RCEL
AVITA Medical Annual Report
Year | Year | 2023 | 2022 | 2020 | 2019 | 2014 | 2013 | 2012 | ||
---|---|---|---|---|---|---|---|---|---|---|
Rev. | Revenue |
|
$50.14M | $34.42M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | |
GM % | Gross Margin % |
|
84.48% | 82.45% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
OM | Operating Margin |
|
-84.89% | -79.91% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
EPS | Earnings Per Share |
|
$0.00 | $-2.14 | $-1.57 | $-2.86 | $-0.03 | $-0.02 | $-0.03 | $-0.47 |
Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
PR % | Payout Ratio % |
|
-0.00% | -0.00% | 0 | 0 | 0 | 0 | 0 | |
Sha. | Shares |
|
25.68m | 25.21m | 108.13m | 105.87m | 16.27m | 16.27m | 3.25m | |
OCF | Operating Cash Flow |
|
$-38.01M | $-19.09M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | |
FCF | Free Cash Flow |
|
$-55.49M | $-28.75M | $-32.26M | $-29.28M | $0.00M | $-7.33M | $0.00M | |
FCFS | Free Cash Flow Per Share |
|
$-1.56 | $-0.78 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |